Home › Ulcerative Colitis › Wisconsin › Milwaukee
Ulcerative Colitis clinical trials in Milwaukee, WI
4 studies for Ulcerative Colitis are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Site US-012, Milwaukee
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Wisconsin Center for Advanced Research, Milwaukee
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Milwaukee
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RecruitingObservational studyHealthy volunteers welcome
- Brain Inflammation Collaborative, Delafield · 25 mi away
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Orlando, FL23 studies
- Miami, FL22 studies
- Houston, TX18 studies
- San Antonio, TX16 studies
- San Diego, CA16 studies
- Tacoma, WA15 studies
- Chicago, IL15 studies
- St. Louis, MO14 studies
- Tyler, TX14 studies
- Colorado Springs, CO14 studies
- Los Angeles, CA13 studies
Other studies in Milwaukee
- Cancer (all types)23 studies
- Breast Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer21 studies
- Multiple Myeloma21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Non-Hodgkin Lymphoma18 studies
- Pancreatic Cancer18 studies
- Acute Myeloid Leukemia17 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.